SG11201705543VA - Sulfonamide pharmaceutical composition - Google Patents

Sulfonamide pharmaceutical composition

Info

Publication number
SG11201705543VA
SG11201705543VA SG11201705543VA SG11201705543VA SG11201705543VA SG 11201705543V A SG11201705543V A SG 11201705543VA SG 11201705543V A SG11201705543V A SG 11201705543VA SG 11201705543V A SG11201705543V A SG 11201705543VA SG 11201705543V A SG11201705543V A SG 11201705543VA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
sulfonamide
sulfonamide pharmaceutical
composition
pharmaceutical
Prior art date
Application number
SG11201705543VA
Other languages
English (en)
Inventor
Yi Juang Wu
Xiaoqing Yao
Changhai Sun
Li Tian
Xinying Zhao
Zhidong Han
Chuangyu Lin
Original Assignee
Tianjin Hongri Jian Da Kang Medical Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Hongri Jian Da Kang Medical Tech Co Ltd filed Critical Tianjin Hongri Jian Da Kang Medical Tech Co Ltd
Publication of SG11201705543VA publication Critical patent/SG11201705543VA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201705543VA 2015-01-06 2016-01-04 Sulfonamide pharmaceutical composition SG11201705543VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201510005995.5A CN104473914B (zh) 2015-01-06 2015-01-06 一种磺酰胺类药物组合物
PCT/CN2016/070015 WO2016110225A1 (zh) 2015-01-06 2016-01-04 一种磺酰胺类药物组合物

Publications (1)

Publication Number Publication Date
SG11201705543VA true SG11201705543VA (en) 2017-08-30

Family

ID=52748619

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201705543VA SG11201705543VA (en) 2015-01-06 2016-01-04 Sulfonamide pharmaceutical composition

Country Status (11)

Country Link
US (2) US20170354621A1 (de)
EP (1) EP3243510B1 (de)
JP (1) JP6502507B2 (de)
KR (1) KR101949810B1 (de)
CN (2) CN104473914B (de)
AU (1) AU2016206154B2 (de)
CA (1) CA2972834C (de)
MX (1) MX2017008983A (de)
RU (1) RU2715700C2 (de)
SG (1) SG11201705543VA (de)
WO (1) WO2016110225A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104473914B (zh) * 2015-01-06 2017-01-11 天津红日药业股份有限公司 一种磺酰胺类药物组合物
CN113368251A (zh) * 2020-02-25 2021-09-10 上海和绎实业有限公司 一种组合溶剂及其制备方法和应用
US11752160B2 (en) 2020-09-24 2023-09-12 Gongwin Biopharm Co., Ltd Method for reducing fat by administering benzenesulfonamide compositions
US20230098310A1 (en) * 2021-09-29 2023-03-30 Gongwin Biopharm Co., Ltd Methods for treating mast cell tumors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891454A (en) * 1997-03-28 1999-04-06 Alexander Wu Anti-cancer drug and special tumor necrotizing agent
US5783705A (en) * 1997-04-28 1998-07-21 Texas Biotechnology Corporation Process of preparing alkali metal salys of hydrophobic sulfonamides
CN1073415C (zh) * 1997-07-03 2001-10-24 吴宜庄 磺酰胺类化合物在制备抗癌药物中的应用
WO1999044642A1 (en) * 1998-03-05 1999-09-10 Phares Pharmaceutical Research Nv Pharmaceutical compositions and their use
US6727287B2 (en) 2001-04-16 2004-04-27 Pts International, Inc. Toluene sulfonamide-containing anti-tumor composition and method of use thereof
CN102389410A (zh) * 2011-11-03 2012-03-28 黄漫翔 对-甲苯磺酰胺在制备癌症治疗药物中的应用
CN104473914B (zh) * 2015-01-06 2017-01-11 天津红日药业股份有限公司 一种磺酰胺类药物组合物

Also Published As

Publication number Publication date
MX2017008983A (es) 2018-03-23
CA2972834A1 (en) 2016-07-14
RU2017126976A3 (de) 2019-08-22
EP3243510B1 (de) 2022-08-31
EP3243510A1 (de) 2017-11-15
KR101949810B1 (ko) 2019-02-19
CN104473914A (zh) 2015-04-01
US20190231721A1 (en) 2019-08-01
AU2016206154A1 (en) 2017-07-27
US11040020B2 (en) 2021-06-22
CN104473914B (zh) 2017-01-11
KR20170095926A (ko) 2017-08-23
JP6502507B2 (ja) 2019-04-17
RU2715700C2 (ru) 2020-03-03
EP3243510A4 (de) 2018-08-08
CA2972834C (en) 2020-07-14
RU2017126976A (ru) 2019-02-08
CN107205974A (zh) 2017-09-26
JP2018501291A (ja) 2018-01-18
AU2016206154B2 (en) 2018-11-01
US20170354621A1 (en) 2017-12-14
WO2016110225A1 (zh) 2016-07-14

Similar Documents

Publication Publication Date Title
IL265360B (en) Pharmaceutical composition
IL265260B (en) pharmaceutical preparations
IL262654A (en) Pharmacy preparation
GB201409488D0 (en) Pharmaceutical composition
IL265349A (en) Pharmaceutical composition
GB201409485D0 (en) Pharmaceutical composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201521462D0 (en) Pharmaceutical composition
SG11201705543VA (en) Sulfonamide pharmaceutical composition
GB201515310D0 (en) Pharmaceutical composition
HK1245073A1 (zh) 藥物組合物
PL3454838T3 (pl) Kompozycja farmaceutyczna
GB201615917D0 (en) Pharmaceutical composition
GB201520862D0 (en) Pharmaceutical composition
IL263999A (en) Pharmaceutical compositions
GB201615914D0 (en) Pharmaceutical composition
GB201615910D0 (en) Pharmaceutical composition
HUE050881T2 (hu) Gyógyszerkészítmény
IL265436B (en) Pharmacy preparation
ZA201705782B (en) Pharmaceutical compositions
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
GB2529605B (en) Pharmaceutical composition
IL265428A (en) Pharmaceutical composition
PT3476391T (pt) Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq
ZA201705783B (en) Pharmaceutical compositions